InvestorsHub Logo
Followers 4
Posts 300
Boards Moderated 0
Alias Born 02/09/2015

Re: hemopure36 post# 15955

Thursday, 09/14/2017 10:51:52 AM

Thursday, September 14, 2017 10:51:52 AM

Post# of 18422

1) I strongly disagree. Delisting from the Nasdaq, which still looks imminent, is a severe blow to an already flatlining company. The funds are just simply drying up at 17 years.
2) You are correct - I know that a reverse split does not cause dilution. But tapping into the ATM funds and selling additional shares DOES. I suspect YOU know this.
3)The reality is Aethlon met the criteria for EAP, mainly on the "no current solution for these conditions" front. Doesnt imply approval. More importantly, it does not imply any demand for the product nor revenue. Nor a timeframe.
4) See above.

Agreed it's good news for the company. But it has to be taken in context. The stock performance after the initial spike speaks volumes. The smart money continues to sell this bump. And the tiny research grant announced this morning is doing nothing to help prop the stock...GLTA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News